Amgen (AMGN) Beats on Q3 Earnings, Ends Neuroscience R&D
Amgen AMGN reported third-quarter 2019 earnings of $3.66 per share, which beat the Zacks Consensus Estimate of $3.51. Earnings declined 1% year over year due to lower revenues and operating profits.
Total revenues of $5.74 billion in the quarter beat the Zacks Consensus Estimate of $5.63 billion. However, total revenues declined 3% year over year.
...
https://finance.yahoo.com/news/amgen-amg...03680.html
Amgen AMGN reported third-quarter 2019 earnings of $3.66 per share, which beat the Zacks Consensus Estimate of $3.51. Earnings declined 1% year over year due to lower revenues and operating profits.
Total revenues of $5.74 billion in the quarter beat the Zacks Consensus Estimate of $5.63 billion. However, total revenues declined 3% year over year.
...
https://finance.yahoo.com/news/amgen-amg...03680.html
__________________